 Gary Ostroff
Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| beta-Glucans | 15 | 2015 | 36 | 1.480 |
Why?
| | Glucans | 10 | 2015 | 27 | 1.030 |
Why?
| | Saccharomyces cerevisiae | 7 | 2015 | 435 | 0.660 |
Why?
| | Fungal Vaccines | 4 | 2015 | 18 | 0.590 |
Why?
| | Cell Wall | 3 | 2014 | 75 | 0.550 |
Why?
| | Gene Transfer Techniques | 2 | 2011 | 206 | 0.450 |
Why?
| | Ascomycota | 2 | 2015 | 9 | 0.440 |
Why?
| | Dendritic Cells | 5 | 2015 | 384 | 0.390 |
Why?
| | Vaccination | 5 | 2015 | 131 | 0.370 |
Why?
| | Ovalbumin | 5 | 2015 | 96 | 0.360 |
Why?
| | Antigens, Fungal | 3 | 2015 | 36 | 0.360 |
Why?
| | DNA | 2 | 2008 | 593 | 0.360 |
Why?
| | Nanoparticles | 2 | 2014 | 245 | 0.330 |
Why?
| | Lectins, C-Type | 3 | 2015 | 66 | 0.310 |
Why?
| | Peyer's Patches | 2 | 2015 | 28 | 0.310 |
Why?
| | Mice | 19 | 2015 | 7196 | 0.310 |
Why?
| | Coccidioides | 2 | 2013 | 7 | 0.280 |
Why?
| | Coccidioidomycosis | 2 | 2013 | 6 | 0.280 |
Why?
| | Anthrax | 1 | 2003 | 14 | 0.280 |
Why?
| | Vaccines | 2 | 2013 | 48 | 0.270 |
Why?
| | Animals | 24 | 2015 | 14283 | 0.270 |
Why?
| | Fungi | 2 | 2014 | 35 | 0.270 |
Why?
| | Anti-Infective Agents | 1 | 2003 | 68 | 0.260 |
Why?
| | Mice, Inbred C57BL | 12 | 2015 | 2223 | 0.260 |
Why?
| | Adjuvants, Immunologic | 4 | 2004 | 194 | 0.260 |
Why?
| | Macrophages | 5 | 2014 | 724 | 0.240 |
Why?
| | CD4-Positive T-Lymphocytes | 5 | 2015 | 513 | 0.230 |
Why?
| | Bacillus subtilis | 3 | 1984 | 23 | 0.220 |
Why?
| | Drug Delivery Systems | 3 | 2013 | 165 | 0.220 |
Why?
| | Plasmids | 3 | 1984 | 243 | 0.210 |
Why?
| | Cloning, Molecular | 3 | 1984 | 358 | 0.200 |
Why?
| | Chitin | 3 | 2014 | 33 | 0.200 |
Why?
| | Cytokines | 5 | 2015 | 697 | 0.200 |
Why?
| | RNA, Small Interfering | 3 | 2014 | 569 | 0.190 |
Why?
| | Genetic Vectors | 3 | 1984 | 474 | 0.170 |
Why?
| | Cryptococcus gattii | 1 | 2015 | 4 | 0.170 |
Why?
| | Candida tropicalis | 1 | 2015 | 2 | 0.170 |
Why?
| | Carbohydrates | 2 | 2014 | 32 | 0.170 |
Why?
| | Complement C3 | 3 | 2012 | 46 | 0.170 |
Why?
| | Mannose-Binding Lectins | 1 | 2015 | 19 | 0.160 |
Why?
| | Antigens | 2 | 2013 | 131 | 0.160 |
Why?
| | Escherichia coli | 3 | 1984 | 562 | 0.160 |
Why?
| | Cryptococcosis | 1 | 2015 | 38 | 0.160 |
Why?
| | Chitosan | 2 | 2014 | 40 | 0.160 |
Why?
| | Calnexin | 1 | 2015 | 5 | 0.160 |
Why?
| | Candida albicans | 1 | 2015 | 49 | 0.160 |
Why?
| | Antigens, Surface | 1 | 2015 | 178 | 0.150 |
Why?
| | Cryptococcus neoformans | 1 | 2015 | 112 | 0.150 |
Why?
| | Hemostatics | 1 | 2014 | 20 | 0.150 |
Why?
| | Epitopes | 1 | 2015 | 240 | 0.150 |
Why?
| | NF-kappa B | 2 | 2014 | 368 | 0.150 |
Why?
| | Immunity, Active | 1 | 2013 | 17 | 0.150 |
Why?
| | Inflammation | 2 | 2009 | 625 | 0.140 |
Why?
| | Myeloid Cells | 1 | 2014 | 54 | 0.140 |
Why?
| | Nerve Tissue Proteins | 2 | 2014 | 341 | 0.140 |
Why?
| | Bone Marrow Cells | 1 | 2014 | 208 | 0.140 |
Why?
| | Mice, Inbred BALB C | 4 | 2014 | 800 | 0.140 |
Why?
| | Huntington Disease | 1 | 2014 | 79 | 0.140 |
Why?
| | Lung | 4 | 2015 | 456 | 0.140 |
Why?
| | Lung Diseases, Fungal | 1 | 2012 | 16 | 0.130 |
Why?
| | Drug Carriers | 1 | 2013 | 85 | 0.130 |
Why?
| | Peritonitis | 1 | 1992 | 21 | 0.130 |
Why?
| | Properdin | 1 | 2011 | 11 | 0.120 |
Why?
| | Cell Proliferation | 1 | 2015 | 661 | 0.120 |
Why?
| | Complement Activation | 1 | 2011 | 34 | 0.120 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2012 | 167 | 0.120 |
Why?
| | Complement Pathway, Alternative | 1 | 2011 | 24 | 0.120 |
Why?
| | Phagocytes | 1 | 2011 | 46 | 0.120 |
Why?
| | Antibodies, Monoclonal | 2 | 2004 | 663 | 0.120 |
Why?
| | Polysaccharides | 1 | 2011 | 88 | 0.120 |
Why?
| | Immunity, Humoral | 1 | 2010 | 31 | 0.110 |
Why?
| | Immunity, Cellular | 1 | 2010 | 175 | 0.110 |
Why?
| | Granulocytes | 2 | 2003 | 52 | 0.100 |
Why?
| | Porosity | 1 | 2008 | 16 | 0.100 |
Why?
| | NIH 3T3 Cells | 1 | 2008 | 81 | 0.100 |
Why?
| | Fluorescence | 1 | 2008 | 72 | 0.100 |
Why?
| | RNA, Transfer | 1 | 2008 | 46 | 0.100 |
Why?
| | Gene Silencing | 1 | 2009 | 244 | 0.090 |
Why?
| | Yeasts | 1 | 2007 | 46 | 0.090 |
Why?
| | Cells, Cultured | 4 | 2014 | 1750 | 0.090 |
Why?
| | Polyethylene Glycols | 1 | 2008 | 119 | 0.090 |
Why?
| | Green Fluorescent Proteins | 1 | 2008 | 286 | 0.090 |
Why?
| | Toll-Like Receptors | 1 | 2009 | 422 | 0.090 |
Why?
| | Microscopy, Fluorescence | 1 | 2008 | 345 | 0.090 |
Why?
| | Protein-Serine-Threonine Kinases | 1 | 2009 | 322 | 0.090 |
Why?
| | Flow Cytometry | 1 | 2008 | 592 | 0.090 |
Why?
| | Transfection | 1 | 2008 | 630 | 0.090 |
Why?
| | Disease Models, Animal | 2 | 2015 | 1161 | 0.080 |
Why?
| | HT29 Cells | 2 | 2015 | 19 | 0.080 |
Why?
| | Caco-2 Cells | 2 | 2015 | 25 | 0.080 |
Why?
| | Signal Transduction | 1 | 2014 | 2232 | 0.080 |
Why?
| | Transformation, Bacterial | 1 | 1983 | 13 | 0.070 |
Why?
| | Hymecromone | 1 | 2003 | 1 | 0.070 |
Why?
| | Trichoderma | 1 | 2003 | 2 | 0.070 |
Why?
| | Serratia marcescens | 1 | 2003 | 4 | 0.070 |
Why?
| | Humans | 12 | 2015 | 33599 | 0.070 |
Why?
| | Acetylglucosamine | 1 | 2003 | 10 | 0.070 |
Why?
| | Streptomyces | 1 | 2003 | 11 | 0.070 |
Why?
| | Mice, Knockout | 3 | 2014 | 1557 | 0.070 |
Why?
| | Biological Warfare | 1 | 2003 | 3 | 0.070 |
Why?
| | Bacillus anthracis | 1 | 2003 | 11 | 0.070 |
Why?
| | Bioterrorism | 1 | 2003 | 15 | 0.070 |
Why?
| | Gingivitis | 1 | 2002 | 4 | 0.070 |
Why?
| | Porphyromonas gingivalis | 1 | 2002 | 21 | 0.070 |
Why?
| | Immunotherapy | 1 | 2003 | 104 | 0.070 |
Why?
| | Neutrophil Infiltration | 1 | 2002 | 31 | 0.070 |
Why?
| | Mice, Inbred Strains | 2 | 2012 | 170 | 0.060 |
Why?
| | Bacterial Infections | 1 | 2002 | 87 | 0.060 |
Why?
| | Survival Rate | 1 | 2003 | 480 | 0.060 |
Why?
| | Lymphoid Tissue | 2 | 2015 | 53 | 0.060 |
Why?
| | Administration, Oral | 2 | 2013 | 198 | 0.060 |
Why?
| | Male | 8 | 2015 | 16940 | 0.060 |
Why?
| | Interleukin-1beta | 2 | 2014 | 181 | 0.060 |
Why?
| | Zymosan | 2 | 2011 | 25 | 0.050 |
Why?
| | Anti-Bacterial Agents | 1 | 2003 | 374 | 0.050 |
Why?
| | Avena sativa | 1 | 1999 | 1 | 0.050 |
Why?
| | Dietary Fiber | 1 | 1999 | 68 | 0.050 |
Why?
| | Neoplasms | 1 | 2004 | 600 | 0.050 |
Why?
| | Treatment Outcome | 2 | 2015 | 2584 | 0.050 |
Why?
| | Lipids | 1 | 1999 | 220 | 0.050 |
Why?
| | Mutation | 1 | 1983 | 1723 | 0.050 |
Why?
| | Psoriasis | 2 | 1973 | 34 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2002 | 662 | 0.040 |
Why?
| | Oligosaccharides | 2 | 2003 | 47 | 0.040 |
Why?
| | Injections, Subcutaneous | 1 | 2015 | 57 | 0.040 |
Why?
| | Substrate Specificity | 2 | 2009 | 253 | 0.040 |
Why?
| | Chromatography, Gel | 1 | 2015 | 61 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2015 | 64 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2015 | 67 | 0.040 |
Why?
| | Th1 Cells | 1 | 2015 | 123 | 0.040 |
Why?
| | Immunization | 1 | 2015 | 116 | 0.040 |
Why?
| | Alveolar Bone Loss | 1 | 1995 | 1 | 0.040 |
Why?
| | Phagocytosis | 2 | 2012 | 193 | 0.040 |
Why?
| | Microscopy, Electron | 1 | 2015 | 243 | 0.040 |
Why?
| | Fungal Proteins | 1 | 2015 | 143 | 0.040 |
Why?
| | Female | 4 | 2014 | 18678 | 0.040 |
Why?
| | Mannans | 1 | 2014 | 13 | 0.040 |
Why?
| | Neutrophil Activation | 1 | 1995 | 21 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2015 | 192 | 0.040 |
Why?
| | Immunoconjugates | 1 | 2014 | 41 | 0.040 |
Why?
| | Mycoses | 1 | 2014 | 38 | 0.040 |
Why?
| | Polyglycolic Acid | 1 | 2014 | 10 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2015 | 136 | 0.040 |
Why?
| | U937 Cells | 1 | 2014 | 11 | 0.040 |
Why?
| | Macrophage-1 Antigen | 2 | 2004 | 28 | 0.040 |
Why?
| | Lactic Acid | 1 | 2014 | 48 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 504 | 0.040 |
Why?
| | Cell Survival | 1 | 2015 | 440 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2014 | 141 | 0.040 |
Why?
| | Immunoglobulin A | 1 | 2013 | 43 | 0.040 |
Why?
| | Genes, Bacterial | 2 | 1984 | 126 | 0.030 |
Why?
| | Gene Expression | 1 | 2015 | 586 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2015 | 899 | 0.030 |
Why?
| | Vaccines, Synthetic | 1 | 2012 | 51 | 0.030 |
Why?
| | Antibodies, Blocking | 1 | 2012 | 35 | 0.030 |
Why?
| | Colony-Forming Units Assay | 1 | 1992 | 23 | 0.030 |
Why?
| | Genotype | 2 | 1984 | 466 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 1992 | 48 | 0.030 |
Why?
| | Leukocyte Count | 1 | 1992 | 82 | 0.030 |
Why?
| | Rats | 2 | 1995 | 1681 | 0.030 |
Why?
| | Immunoblotting | 1 | 2012 | 185 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 1992 | 165 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2013 | 328 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 1992 | 139 | 0.030 |
Why?
| | Bacteria | 1 | 1973 | 135 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 395 | 0.030 |
Why?
| | 3T3-L1 Cells | 1 | 2011 | 75 | 0.030 |
Why?
| | Ligands | 1 | 2012 | 331 | 0.030 |
Why?
| | Phenotype | 2 | 1984 | 787 | 0.030 |
Why?
| | Base Sequence | 2 | 1984 | 1208 | 0.030 |
Why?
| | COS Cells | 1 | 2011 | 179 | 0.030 |
Why?
| | Cercopithecus aethiops | 1 | 2011 | 162 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2012 | 601 | 0.030 |
Why?
| | Particle Size | 1 | 2011 | 244 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2014 | 540 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2014 | 592 | 0.030 |
Why?
| | Uridine Diphosphate Sugars | 1 | 1989 | 2 | 0.030 |
Why?
| | Uridine Diphosphate Glucuronic Acid | 1 | 1989 | 3 | 0.030 |
Why?
| | Lactose | 1 | 1989 | 5 | 0.030 |
Why?
| | Cytidine Monophosphate N-Acetylneuraminic Acid | 1 | 1989 | 9 | 0.030 |
Why?
| | Organ Specificity | 1 | 2009 | 143 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 98 | 0.030 |
Why?
| | Hyaluronic Acid | 1 | 1989 | 23 | 0.030 |
Why?
| | Sialic Acids | 1 | 1989 | 27 | 0.030 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 108 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2009 | 315 | 0.020 |
Why?
| | Down-Regulation | 1 | 2009 | 243 | 0.020 |
Why?
| | Up-Regulation | 1 | 2009 | 305 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2009 | 150 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 1195 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2009 | 462 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 511 | 0.020 |
Why?
| | Fusaric Acid | 1 | 1984 | 1 | 0.020 |
Why?
| | Chimera | 1 | 1984 | 37 | 0.020 |
Why?
| | Complement C3b | 1 | 2003 | 15 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 1984 | 56 | 0.020 |
Why?
| | DNA Restriction Enzymes | 1 | 1984 | 30 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2009 | 641 | 0.020 |
Why?
| | Brachyura | 1 | 2003 | 1 | 0.020 |
Why?
| | Complex Mixtures | 1 | 2003 | 3 | 0.020 |
Why?
| | Chromatography, Thin Layer | 1 | 2003 | 15 | 0.020 |
Why?
| | Disaccharides | 1 | 2003 | 10 | 0.020 |
Why?
| | Nephelometry and Turbidimetry | 1 | 2003 | 11 | 0.020 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 2003 | 8 | 0.020 |
Why?
| | Trisaccharides | 1 | 2003 | 8 | 0.020 |
Why?
| | Glucosamine | 1 | 2003 | 9 | 0.020 |
Why?
| | Nucleic Acid Hybridization | 1 | 1983 | 92 | 0.020 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 2003 | 49 | 0.020 |
Why?
| | Colloids | 1 | 2003 | 31 | 0.020 |
Why?
| | Hydrolysis | 1 | 2003 | 102 | 0.020 |
Why?
| | Species Specificity | 1 | 1983 | 290 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2003 | 161 | 0.020 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2002 | 44 | 0.020 |
Why?
| | Models, Animal | 1 | 2002 | 168 | 0.020 |
Why?
| | Kinetics | 1 | 2003 | 701 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 2003 | 258 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2002 | 525 | 0.010 |
Why?
| | Neutrophils | 1 | 2002 | 262 | 0.010 |
Why?
| | Cell Movement | 1 | 2002 | 332 | 0.010 |
Why?
| | Carbohydrate Conformation | 1 | 1999 | 12 | 0.010 |
Why?
| | Hypercholesterolemia | 1 | 1999 | 65 | 0.010 |
Why?
| | History, 20th Century | 1 | 1999 | 160 | 0.010 |
Why?
| | Adult | 1 | 2011 | 9623 | 0.010 |
Why?
| | Cholesterol | 1 | 1999 | 223 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 1999 | 290 | 0.010 |
Why?
| | Time Factors | 1 | 2002 | 2552 | 0.010 |
Why?
| | Dental Pulp Necrosis | 1 | 1995 | 1 | 0.010 |
Why?
| | Bacteria, Anaerobic | 1 | 1995 | 4 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1995 | 62 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 1995 | 358 | 0.010 |
Why?
| | Regression Analysis | 1 | 1995 | 422 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1995 | 447 | 0.010 |
Why?
| | Sterilization | 1 | 1972 | 11 | 0.010 |
Why?
| | Wound Healing | 1 | 1972 | 121 | 0.010 |
Why?
| | Skin | 1 | 1972 | 227 | 0.010 |
Why?
| | Cytidine Triphosphate | 1 | 1989 | 1 | 0.010 |
Why?
| | Clostridium perfringens | 1 | 1989 | 4 | 0.010 |
Why?
| | Indicators and Reagents | 1 | 1989 | 47 | 0.010 |
Why?
| | Neuraminidase | 1 | 1989 | 32 | 0.010 |
Why?
| | N-Acetylneuraminic Acid | 1 | 1989 | 33 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1989 | 225 | 0.010 |
Why?
| | Oxidoreductases | 1 | 1960 | 40 | 0.000 |
Why?
| | Viruses | 1 | 1960 | 62 | 0.000 |
Why?
| | Fatty Acids | 1 | 1960 | 136 | 0.000 |
Why?
| | Hodgkin Disease | 1 | 1956 | 46 | 0.000 |
Why?
| | Immunity | 1 | 1956 | 60 | 0.000 |
Why?
| | Surgical Wound Infection | 1 | 1972 | 56 | 0.000 |
Why?
| | Staphylococcal Infections | 1 | 1972 | 71 | 0.000 |
Why?
|
|
Ostroff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|